Michael Har-Noy
Impact in
- Pharmacology top 5%
- Cannabis and Cannabinoid Research
-
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
Papers in
-
- Immunotherapy and Immune Responses 8
- Immune Cell Function and Interaction 7
- T-cell and B-cell Immunology 3
- Oncology 5
- Cancer Immunotherapy and Biomarkers 3
- Colorectal Cancer Treatments and Studies 1
- Co-authors
- Michael Zeira (3 shared papers)Lola Weiss (3 shared papers)Ruth Gallily (1 shared paper)Raphael Mechoulam (1 shared paper)S Reich (1 shared paper)Shimon Slavin (1 shared paper)S Slavin (3 shared papers)Reuven Or (4 shared papers)
- Journals
- Journal of Clinical Oncology (4 papers)Leukemia Research (2 papers)International Journal of Hyperthermia (2 papers)Journal of Translational Medicine (1 paper)Blood (1 paper)
- Partner nations
- IsraelUnited StatesThailand
In The Last Decade
Michael Har-Noy
13 papers receiving 294 citations
Peers
Comparison fields: 5 of 60
- Pharmacology 160
- Immunology 82
- Endocrinology, Diabetes and Metabolism 50
- Biological Psychiatry 5
- Oncology 46
Countries citing papers authored by Michael Har-Noy
This map shows the geographic impact of Michael Har-Noy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Har-Noy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Har-Noy more than expected).
Fields of papers citing papers by Michael Har-Noy
This network shows the impact of papers produced by Michael Har-Noy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Har-Noy. The network helps show where Michael Har-Noy may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Har-Noy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 181 | |
| 2 | 2011 | 39 | |
| 3 | 2010 | 18 | |
| 4 | 2013 | 12 | |
| 5 | 2007 | 11 | |
| 6 | 2008 | 10 | |
| 7 | 2008 | 9 | |
| 8 | 2020 | 9 | |
| 9 | 2013 | 8 | |
| 10 | 2018 | 4 | |
| 11 | 2012 | 2 | |
| 12 | 2018 | 1 | |
| 13 | A New Strategy for Immunotherapy of Cancer | 2009 | 1 |
| 14 | 2024 | 0 | |
| 15 | 2018 | 0 |
About Michael Har-Noy
Michael Har-Noy is a scholar working on Immunology, Oncology, Biotechnology, Surgery and Hepatology, having authored 15 papers that have together received 305 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (8 papers), Immune Cell Function and Interaction (7 papers), T-cell and B-cell Immunology (3 papers), Cancer Research and Treatments (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Colorectal Cancer Treatments and Studies (1 paper) and Veterinary Oncology Research (1 paper). The work is most often cited by research in Pharmacology (160 citations), Immunology (82 citations), Endocrinology, Diabetes and Metabolism (50 citations), Biological Psychiatry (5 citations) and Oncology (46 citations). Michael Har-Noy has collaborated with scholars based in Israel, United States and Thailand. Frequent co-authors include Michael Zeira, Lola Weiss, Ruth Gallily, Raphael Mechoulam, S Reich, Shimon Slavin, S Slavin, Reuven Or, Emmanuel Katsanis and Bernard Bonnotte. Their work appears in journals such as Journal of Clinical Oncology, Leukemia Research, International Journal of Hyperthermia, Journal of Translational Medicine and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.